Bahrain approves Valneva's COVID vaccine for emergency use

Middle East
01-03-2022 | 03:23
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
Bahrain approves Valneva's COVID vaccine for emergency use
Whatsapp
facebook
Twitter
Messenger
telegram
telegram
print
0min
Bahrain approves Valneva's COVID vaccine for emergency use
Bahrain has granted emergency use authorization to the COVID-19 vaccine developed by France's Valneva VLS.PA, the company said in a statement on Tuesday.

Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March, after it signed an advance purchase deal for one million doses in December last year.

"As the only dual-adjuvanted, inactivated COVID-19 vaccine approved in Bahrain, VLA2001 will provide a differentiated vaccine option to the Bahraini population and medical community," said CEO Thomas Lingelbach.

Late last month, the company had said it expected to start shipments of its vaccine in Europe soon after it is recommended for conditional approval at the end of March, as it received a list of questions in an initial regulatory assessment. 
 
 
 
 
REUTERS

Breaking Headlines

Bahrain

Covid19.

Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More